ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 437 filers reported holding ENCOMPASS HEALTH CORP in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806 | -0.9% | 12 | 0.0% | 0.00% | – |
| Q2 2023 | $813 | +25.3% | 12 | 0.0% | 0.00% | – |
| Q1 2023 | $649 | -93.1% | 12 | -92.4% | 0.00% | -100.0% |
| Q4 2022 | $9,450 | +845.0% | 158 | +1216.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 12 | -47.8% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 23 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 23 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $1,000 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |